Perforomist

Asthma, Bronchoconstriction, maintenance therapy + 6 more
Treatment
20 Active Studies for Perforomist

What is Perforomist

FormoterolThe Generic name of this drug
Treatment SummaryFormoterol is an inhalable medication used to treat COPD and asthma. It helps to relax and open the airways, providing relief from symptoms. It works quickly (within 2-3 minutes) and lasts for up to 12 hours. It is available on its own or in combination with other medications such as corticosteroids and long-acting muscarinic antagonists. It was approved by the FDA in 2001.
Foradilis the brand name
image of different drug pills on a surface
Perforomist Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Foradil
Formoterol
2001
37

Effectiveness

How Perforomist Affects PatientsFormoterol helps open up the airways in the lungs and makes it easier to breathe. It works quickly (around 2-3 minutes) and can last up to 12 hours. People with asthma should not take this alone, as it may increase the risk of death due to asthma.
How Perforomist works in the bodyFormoterol is a drug that helps open up airways and reduce swelling in the lungs. It works by targeting specific receptors in the lungs that cause airways to narrow. By activating these receptors, it increases the production of a molecule that helps relax and widen airway muscles, while also reducing the release of substances that cause inflammation.

When to interrupt dosage

The quantity of Perforomist is contingent upon the identified illness, including Bronchial Asthma, Bronchoconstriction and Asthma. The dosage fluctuates according to the delivery mode (e.g. Solution - Respiratory (inhalation) or Aerosol) featured in the table below.
Condition
Dosage
Administration
Chronic Obstructive Pulmonary Disease
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)
Asthma
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)
Bronchoconstriction
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)
maintenance therapy
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)
Asthma, Exercise-Induced
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)
Chronic Obstructive Airway Disease
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)
Asthma
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)
Chronic Obstructive Airway Disease
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)
Pulmonary Disease, Chronic Obstructive
, 0.012 mg, 0.005 mg, 0.02 mg/mL, 0.0048 mg, 0.0045 mg, 0.009 mg, 0.012 mg/pump actuation, 0.0058 mg/pump actuation, 0.006 mg/pump actuation, 0.005 mg/pump actuation
, Respiratory (inhalation), Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Solution, Solution - Respiratory (inhalation)

Warnings

Perforomist has four contraindications. It should be avoided when dealing with any of the conditions stipulated in the following table.Perforomist Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Formoterol may interact with Pulse Frequency
Status Asthmaticus
Do Not Combine
Asthma
Do Not Combine
Status Asthmaticus
Do Not Combine
There are 20 known major drug interactions with Perforomist.
Common Perforomist Drug Interactions
Drug Name
Risk Level
Description
Amoxapine
Major
The metabolism of Amoxapine can be decreased when combined with Formoterol.
Astemizole
Major
The metabolism of Astemizole can be decreased when combined with Formoterol.
Clomipramine
Major
The metabolism of Clomipramine can be decreased when combined with Formoterol.
Cyclophosphamide
Major
The metabolism of Cyclophosphamide can be decreased when combined with Formoterol.
Dacomitinib
Major
The metabolism of Dacomitinib can be decreased when combined with Formoterol.
Perforomist Toxicity & Overdose RiskThe toxic dose of formoterol in rats has been found to be 3130mg/kg. Potential symptoms of overdose include chest pain, high or low blood pressure, rapid heartbeat, nervousness, headache, tremors, seizures, and dry mouth. Lab tests may show low potassium levels, high blood sugar, and acidosis. Treatment of an overdose should focus on providing supportive care and monitoring the patient's heart rate. It may also be helpful to use a medication that blocks certain types of adrenergic stimulation.
image of a doctor in a lab doing drug, clinical research

Perforomist Novel Uses: Which Conditions Have a Clinical Trial Featuring Perforomist?

251 active studies are currently investigating the effectiveness of Perforomist in managing Chronic Obstructive Pulmonary Disease (COPD), Moderate to Severe COPD and Chronic Obstructive Airways Disease.
Condition
Clinical Trials
Trial Phases
Chronic Obstructive Pulmonary Disease
85 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4
Chronic Obstructive Airway Disease
6 Actively Recruiting
Not Applicable, Phase 4
maintenance therapy
0 Actively Recruiting
Chronic Obstructive Airway Disease
0 Actively Recruiting
Pulmonary Disease, Chronic Obstructive
0 Actively Recruiting
Asthma, Exercise-Induced
1 Actively Recruiting
Not Applicable
Asthma
1 Actively Recruiting
Phase 4
Bronchoconstriction
0 Actively Recruiting
Asthma
88 Actively Recruiting
Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 1, Phase 3

Perforomist Reviews: What are patients saying about Perforomist?

5Patient Review
11/1/2013
Perforomist for COPD with Chronic Bronchitis
At first, I had a burning sensation in the back of my throat. But after five days of use, my symptoms got worse. I started having a tight chest and severe wheezing. It became difficult to breathe, so I went to see a doctor.
5Patient Review
3/10/2013
Perforomist for COPD with Chronic Bronchitis
This medication has really helped me out and made a big difference in my life.
5Patient Review
10/10/2010
Perforomist for Emphysema
The only side effects I experience are dry mouth, losing my voice occasionally, and sometimes feeling off-balance.
5Patient Review
12/23/2007
Perforomist for Bronchi Muscle Spasm resulting from COPD
5Patient Review
10/23/2008
Perforomist for Chronic Bronchitis
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about perforomist

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the generic for Perforomist?

"Both Perforomist and Brovana are brand-name drugs and there are no generic forms currently available."

Answered by AI

Is Perforomist a steroid?

"Formoterol relaxes the muscles that allow air to enter the lungs, rather than being a steroid. It is classified as a long-acting beta-agonist (LABA)."

Answered by AI

What are the side effects of Perforomist?

"You may experience some, all, or none of the following side effects while taking Perforomist: shakiness (tremor), nausea, headache, nervousness, dizziness, dry mouth, trouble sleeping (insomnia), anxiety, back pain, muscle cramps, sore throat, cough, stuffy nose, skin rash, itching, or changes in your voice."

Answered by AI

What is Perforomist used for?

"PERFOROMIST Inhalation Solution is a medication used to control the symptoms of COPD in adults. COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both. PERFOROMIST Inhalation Solution is only for use with a nebulizer."

Answered by AI

Clinical Trials for Perforomist

Have you considered Perforomist clinical trials? We made a collection of clinical trials featuring Perforomist, we think they might fit your search criteria.
Have you considered Perforomist clinical trials? We made a collection of clinical trials featuring Perforomist, we think they might fit your search criteria.
Have you considered Perforomist clinical trials? We made a collection of clinical trials featuring Perforomist, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top